Read on Twitter
Top 20 of 2020 Thread: Has been a challenging year, but grateful to our research group that has worked hard, adapted and evolved to still push the field forward. This thread highlights our group’s top 20 pubs of 2020. Great work MDPU/@UofTPsyc/ @UHN/ http://CRTCE.com team!
1/20 State of the art update on Bipolar Disorders published in @TheLancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31544-0/fulltext
2/20 The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder. Published in JAD @ISADTweet https://doi.org/10.1016/j.jad.2020.05.088
3/20 The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis published in JAD @ISADTweet https://doi.org/10.1016/j.jad.2020.06.050
4/20 The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder. Published in Bipolar Disorders @WileyEducation https://doi.org/10.1111/bdi.12941
5/20 Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine. Published in Progress in NP & NB @ELSneuroscience https://doi.org/10.1016/j.pnpbp.2020.110126
6/20 Is ketamine a litmus test for capacity in assisted dying with depression? Published in Pyscho-oncology @IPOSPsychoOncol https://doi.org/10.1002/pon.5586
7/20 Effectiveness of Intravenous ketamine in Mood Disorder Patients with a History of Neurostimulation published in @CNS_Spectrums https://doi.org/10.1017/s1092852920002187
8/20 Changes in symptoms of #anhedonia in adults with major depressive or bipolar disorder receiving IV #ketamine. Published in JAD @ISADTweet https://doi.org/10.1016/j.jad.2020.07.083
9/20 The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety. Published in Journal of Psychopharmacology @SAGEJournals https://doi.org/10.1177/0269881120954048
10/20 Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder. Published in @ExpertOpinion on Drug Safety https://doi.org/10.1080/14740338.2020.1776699
11/20 Registered clinical trials investigating ketamine for psychiatric disorders. Published in Journal of Psychiatry Research @ELSneuroscience @els_psychiatry https://doi.org/10.1016/j.jpsychires.2020.03.020
12/20 Does Body Mass Index #BMI Predict Response to Intravenous Ketamine Treatment in Adults with Major Depressive and Bipolar Disorder? published in @CNS_Spectrums https://doi.org/10.1017/s1092852920002102
13/20 Depression in the medically ill. A comprehensive summary published and featured on the cover of ANZJP @RANZCP https://doi.org/10.1177/0004867419888576
14/20 Development and implementation of guidelines for the management of depression: a systematic review published in @WHO Bulletin https://doi.org/10.2471/blt.20.251405
15/20 Intravenous ketamine for postmenopausal women with treatment-resistant depression. Published in Journal of Psychiatry Research @els_psychiatry https://doi.org/10.1016/j.jpsychires.2020.08.002
16/20 The Prevalence of Suicidal Behaviour in Fibromyalgia Patients. Published in Progress in NP & NB @ELSneuroscience https://doi.org/10.1016/j.pnpbp.2020.110078
17/20 Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. Published in Progress in NP & NB @ELSneuroscience https://doi.org/10.1016/j.pnpbp.2020.110032
18/20 Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders. Published in Psychiatry Research @ELSneuroscience @els_psychiatry https://doi.org/10.1016/j.psychres.2020.112967
19/20 The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis. Published in Psychiatry Research @ELSneuroscience @els_psychiatry https://doi.org/10.1016/j.psychres.2020.113514
20/20 The Mental Health Effects of COVID-19 on Health Care Providers in China. Published in American Journal of Psychiatry @APAPsychiatric https://doi.org/10.1176/appi.ajp.2020.20040374
Big thanks to all the funders, students, volunteers, doctors, nurses, research coordinators, research assistants and co-investigators for your tremendous efforts. And above all, thank you to the patient-participants that volunteered to be part of our studies. Thank you all!
